医学资讯CTNNB1突变RIPPLY1
RIPPLY1:CTNNB1突变型肝细胞癌中的“守护者”
By MedXY|2026年7月31日
RIPPLY1通过靶向TBX19抑制癌症干性,并通过抑制肿瘤进展改善CTNNB1突变型肝细胞癌的预后。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.